Longeveron Inc. Share Price & Technical Analysis
LGVN · $0.80 (+5.26%)
Healthcare / Biotechnology
$0.80
+5.26%
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; comp…
Price chart
Seasonality
Jun has 2 positive and 1 negative years (last 5 years shown)
0% return in Jun, 19% avg return in past 3 year Jun month.
82% return in 2026, -102% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 20% | -17% | 100% | -10% | -11% | 0% | – | – | – | – | – | – | 82% |
| 25 | -17% | 0% | -6% | 6% | -33% | 0% | 23% | -50% | 0% | 0% | -22% | -29% | -128% |
| 24 | -62% | -4% | -42% | -47% | -35% | 45% | 94% | -35% | -5% | 11% | -5% | -15% | -100% |
| 23 | 22% | -10% | -24% | 6% | 6% | 13% | 0% | -19% | -22% | -17% | -1% | -34% | -79% |
| 22 | -37% | -10% | 108% | -36% | -22% | -27% | 5% | -23% | -23% | -3% | 7% | -17% | -78% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$23.95M
P/E ratio
—
52W high
$1.80
52W low
$0.47
Volume
3,25,115
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Longeveron Inc. share price today?
- Longeveron Inc. (LGVN) last traded around $0.80 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LGVN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LGVN. Download the app for real-time alerts.
- How can I analyze Longeveron Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.